PL373219A1 - Infertility treatment with exemestane - Google Patents
Infertility treatment with exemestaneInfo
- Publication number
- PL373219A1 PL373219A1 PL03373219A PL37321903A PL373219A1 PL 373219 A1 PL373219 A1 PL 373219A1 PL 03373219 A PL03373219 A PL 03373219A PL 37321903 A PL37321903 A PL 37321903A PL 373219 A1 PL373219 A1 PL 373219A1
- Authority
- PL
- Poland
- Prior art keywords
- exemestane
- infertility treatment
- infertility
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Reproductive Health (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US39332002P | 2002-07-02 | 2002-07-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
PL373219A1 true PL373219A1 (en) | 2005-08-22 |
Family
ID=30115565
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL03373219A PL373219A1 (en) | 2002-07-02 | 2003-07-02 | Infertility treatment with exemestane |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP1531829A2 (en) |
JP (1) | JP2005536490A (en) |
KR (1) | KR20050077045A (en) |
CN (1) | CN1665516A (en) |
AU (1) | AU2003247404A1 (en) |
BR (1) | BR0312393A (en) |
CA (1) | CA2491372A1 (en) |
IL (1) | IL165813A0 (en) |
MX (1) | MXPA05000251A (en) |
PL (1) | PL373219A1 (en) |
WO (1) | WO2004004634A2 (en) |
ZA (1) | ZA200410135B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102432156B1 (en) * | 2020-05-18 | 2022-08-11 | 제주대학교 산학협력단 | Composition comprising chemical material for inhibiting gonadal maturation in fishes and method for inhibiting gonadal maturation in fishes using the same |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20040025916A (en) * | 2001-04-17 | 2004-03-26 | 아레스 트레이딩 에스.에이. | Single dose aromatase inhibitor for treating infertility |
ES2283541T3 (en) * | 2001-04-17 | 2007-11-01 | Ares Trading S.A. | INHIBITION OF AROMATASE TO IMPROVE THE IMPLEMENTATION INDEX. |
-
2003
- 2003-07-02 KR KR1020057000051A patent/KR20050077045A/en not_active Application Discontinuation
- 2003-07-02 PL PL03373219A patent/PL373219A1/en not_active Application Discontinuation
- 2003-07-02 AU AU2003247404A patent/AU2003247404A1/en not_active Abandoned
- 2003-07-02 CN CN038157306A patent/CN1665516A/en active Pending
- 2003-07-02 MX MXPA05000251A patent/MXPA05000251A/en unknown
- 2003-07-02 CA CA002491372A patent/CA2491372A1/en not_active Abandoned
- 2003-07-02 WO PCT/US2003/016252 patent/WO2004004634A2/en active Application Filing
- 2003-07-02 EP EP03762980A patent/EP1531829A2/en not_active Withdrawn
- 2003-07-02 BR BR0312393-6A patent/BR0312393A/en not_active IP Right Cessation
- 2003-07-02 JP JP2004519563A patent/JP2005536490A/en active Pending
-
2004
- 2004-12-16 IL IL16581304A patent/IL165813A0/en unknown
-
2005
- 2005-12-15 ZA ZA200410135A patent/ZA200410135B/en unknown
Also Published As
Publication number | Publication date |
---|---|
MXPA05000251A (en) | 2005-07-15 |
EP1531829A2 (en) | 2005-05-25 |
CA2491372A1 (en) | 2004-01-15 |
BR0312393A (en) | 2005-04-12 |
IL165813A0 (en) | 2006-01-15 |
KR20050077045A (en) | 2005-07-29 |
WO2004004634A2 (en) | 2004-01-15 |
CN1665516A (en) | 2005-09-07 |
ZA200410135B (en) | 2006-07-26 |
WO2004004634A3 (en) | 2004-04-08 |
AU2003247404A1 (en) | 2004-01-23 |
JP2005536490A (en) | 2005-12-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0213599D0 (en) | Process | |
GB0210143D0 (en) | Process | |
GB0211789D0 (en) | Process | |
GB0213485D0 (en) | Process | |
GB0205016D0 (en) | Process | |
HK1060840A1 (en) | Massager | |
GB0201505D0 (en) | Process | |
GB0210455D0 (en) | Treatment system | |
GB0210225D0 (en) | Process | |
GB0202564D0 (en) | Process | |
GB0205014D0 (en) | Process | |
GB0221157D0 (en) | Novel treatment | |
GB0201378D0 (en) | Process | |
IL165813A0 (en) | Infertility treatment with exemestane | |
GB0202563D0 (en) | Process | |
GB0219104D0 (en) | Trouser-type massager | |
GB0212974D0 (en) | Process | |
GB0219292D0 (en) | Process | |
GB0210183D0 (en) | Process | |
GB0218014D0 (en) | Process | |
GB0213461D0 (en) | Baths | |
GB0203665D0 (en) | Process | |
GB0212821D0 (en) | Eyewash | |
GB0210185D0 (en) | Process | |
GB0213493D0 (en) | Treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |